Overview

The objective of study was to analyze the pattern and compare portfolio of drugs in pipeline to those being translated to FDA approval stage.

Key drivers and challenges were also identified with respect to drugs in various therapeutic domains along with unmet medical needs.

Issues and Concerns:

  • Fewer FDA Approvals

fewer-fda-approvals

  • Blockbusters v/s Targeted Therapeuticsblockbusters-vs-targeted-therapeutics
  • Drug Safety

drug-safety

  • Political Landscape

political-landscape